The Chinese Laboratory Spokesperson CanSino Biologics, Adolfo Hernández Garduño, confirmed this Wednesday that “agreements are being closed” with the national government and some provinces such as Córdoba so that the Convidecia vaccine “I arrived in Argentina in a matter of days.”
Currently, “there are several negotiation processes with the provinces that are not yet closed,” but they are “moving forward,” he said. Hernández Garduño to channel 12 of Córdoba.
As he explained, negotiations began to accelerate this Saturday, June 12, after the national government, through the National Administration of Medicines, Food and Medical Technology (Anmat), made official the Authorization of emergency of the Convidecia vaccine.
Regarding the inclusion in the contrary of some extraordinary legal clause by the Chinese company, the spokesperson said that, since it is an approval for emergency use, “everything related to the handling of the vaccine is the responsibility of the territory. Argentino “, from the” Ministry of Health, the authorities and the local Government “.
This Monday, meanwhile, the Government of Córdoba announced the purchase of one million doses of the Convidecia vaccine that could arrive at the end of next July or the beginning of August.
Vaccine Convidecia
The CanSino Biologics coronavirus vaccine is single dose and has an efficiency of 65%. “This means that 65 out of 100 people who come into contact with the virus will not develop the disease,” said Hernández Garduño.
About the remaining 35%, the spokesperson indicated that “90% of those people, that is, 9 out of 10 will not develop a severe form (of the disease), but in a mild and moderate way. “
The Convidecia vaccine is easy and safe to use because it only needs one temperature 2 to 8 degrees centigrade for its conservation.
– .
